Systemic inflammation, metabolic syndrome and progressive renal disease

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1384-1387

  Cirillo, Pietro ^a,b   Sautin, Yuri Y ^a   Kanellis, John ^c   Kang, Duk Hee ^d   Gesualdo, Loreto ^b   Nakagawa, Takahiko ^e   Johnson, Richard J ^e  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FOGGIA   (Italy)

^c MONASH MEDICAL CENTRE   (Australia)

^d Ewha Womans University School of Medicine   (South Korea)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Fructose; Metabolic syndrome; Monocyte chemoattractant protein 1; Uric acid

Indexed keywords

FRUCTOSE; MONOCYTE CHEMOTACTIC PROTEIN 1; URIC ACID;

CHRONIC KIDNEY DISEASE; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

C-REACTIVE PROTEIN; CHEMOKINE CCL2; DISEASE PROGRESSION; FRUCTOSE; HUMANS; INFLAMMATION; KIDNEY DISEASES; METABOLIC SYNDROME X; URIC ACID;

EID: 65249112126     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp038     Document Type: Review

References (46)

1. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004; 29: 439-443
2. Albert CM, Ma J, Rifai N et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105: 2595-2599
3. Ridker PM, Hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843
4. Soriano S, González L, Martín-Malo A et al. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients. Clin Nephrol 2007; 67: 352-357
5. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414
6. Hovens MM, Snoep JD, Groeneveld Y et al. Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial.Diabetes Obes Metab 2008; 10: 668-674
7. Asher J, Houston M. Statins and C-reactive protein levels.J Clin Hypertens 2007; 9: 622-628
8. Voleti B, Agrawal A. Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist.Mol Immunol 2006; 43: 891-896
9. Di Napoli M, Papa F. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke. Stroke 2003; 34: 2922-2929
10. Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.Altern Med Rev 2001; 6: 248-271
11. National Cholesterol Education Program. Third Reportof the National Cholesterol Education Program (NCEP) on Detection and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421
12. Klausen KP, Parving HH, Scharling H et al. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.J Intern Med 2007; 262: 470-478
13. Khashab MA, Liangpunsakul S, Chalasani N. Nonalcoholic fatty liver disease as a component of the metabolic syndrome.Curr Gastroenterol Rep 2008; 10: 73-80
14. Kim JA, Montagnani M, Koh KK et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888-1904
15. Nakagawa T, Tuttle KR, Short RA et al. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.Nat Clin Pract Nephrol 2005; 1: 80-86
16. Calabro P, Yeh ET. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk.Curr Hypertens Rep 2008; 10: 32-38
17. Greenfield JR, Campbell LV. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Curr Diabetes Rev 2006; 2: 195-211
18. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004; 140: 167- 174
19. Kurella M, Lo JC, Chertow GM. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005; 16: 2134-2140
20. Ko GT, Chan JC. Burden of obesity - lessons learnt from Hong Kong Chinese.Obes Rev 2008; 9(Suppl 1): 35-40
21. Gaby AR. Adverse effects of dietary fructose.Altern Med Rev 2005; 10: 294-306
22. Elliott SS, Keim NL, Stern JS et al. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002; 76: 911-922
23. Hwang IS, Ho H, Hoffman BB et al. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987; 10: 512-516
24. Glushakova O, Kosugi T, Roncal C et al. Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol 2008; 19: 1712-1720
25. Dwyer JT, Evans M, Stone EJ et al. Child and Adolescent Trial for Cardiovascular Health (CATCH) Cooperative Research Group. Adolescents' eating patterns influence their nutrient intakes.J Am Diet Assoc 2001; 101: 798-802
26. Stanhope KL, Griffen SC, Bair BR et al. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals.Am J Clin Nutr 2008; 87: 1194-1203
27. Gersch MS, Mu W, Cirillo P et al. Fructose but not dextrose accelerates the progression of chronic kidney disease.Am J Physiol Renal Physiol 2007; 293: F1256-F1261
28. Mu W, Ouyang X, Agarwal A et al. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005; 16: 3651-3660
29. Mu W, Long DA, Ouyang X et al. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism.Am J Physiol Renal Physiol 2009; 296: F145-F152
30. Mäenpää PH, Raivio KO, Kekomäki MP. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science 1968; 161: 1253-1254
31. Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005; 63: 133-157
32. Stirpe F, Della Corte E, Bonetti E et al. Fructose-induced hyperuri-caemia. Lancet 1970; 2: 1310-1311
33. Gao X, Qi L, Qiao N et al. Intake of added sugar and sugar-sweetened drink and serum UA concentration in US men and women. Hypertension 2007; 50: 306-312
34. Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study.Br Med J 2008; 336: 309-312
35. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia.Am J Med 2007; 120: 442-447
36. Ames BN, Cathcart R, Schwiers E et al. Uric acid provides an antioxi-dant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proc Natl Acad Sci USA 1981; 78: 6858-6862
37. Muraoka S, Miura T. Inhibition by uric acid of free radicals that damage biological molecules.Pharmacol Toxicol 2003; 93: 284-289
38. Kanellis J, Watanabe S, Li JH et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-1293
39. Kang DH, Han L, Ouyang X et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005; 25: 425-433
40. Corry DB, Eslami P, Yamamoto K et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275
41. Sautin YY, Nakagawa T, Zharikov S et al. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.Am J Physiol Cell Physiol 2007; 293: C584-C596
42. Cirillo P, Gersch MS, Mu W et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 2009 Jan 21 [E-pub].
43. Roncal CA, Mu W, Croker B et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure.Am J Physiol Renal Physiol 2007; 292: F116-F122
44. Kang DH, Nakagawa T, Feng L et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888-2897
45. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces en-dothelial dysfunction. Kidney Int 2005; 67: 1739-1742
46. Kang DH, Park SK, Lee IK et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553- 3562